David Chou, | |
University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195-0001 | |
(206) 598-6131 | |
Not Available |
Full Name | David Chou |
---|---|
Gender | Male |
Speciality | Pathology - Clinical Pathology/laboratory Medicine |
Location | University Of Washington Medical Ctr, Seattle, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053496851 | NPI | - | NPPES |
230150 | Other | INTERNAL ID-MOTOR VEHICLE ID | |
0230892 | Other | WA | L&I |
1053496851 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | MD00036317 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
David Chou, Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | David Chou, University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195-0001 Ph: (206) 598-6131 |
News Archive
FDA and Congress "should protect physicians' and patients' right" to use FDA-approved drugs for off-label uses "and for the first time allow drugmakers to promote off-label uses that prove beneficial," Richard Epstein, a law professor at the University of Chicago and a senior fellow at the Hoover Institution, writes in a Wall Street Journal opinion piece. He continues, "Right now these drugs provide immense lifesaving opportunities for many sick patients, particularly those threatened by cancer."
According to the California Department of Motor Vehicles (CADMV), distracted driving is on the rise due to an increase in the use of cell phones and other electronic devices and the increasing importance of these devices in individuals' lives. Studies have shown that phoning and driving increases the risk of crashes four-fold, with hands free and hand held devices equally dangerous. Texting increases this risk 8-16 times.
Actavis plc today announced that it has completed its acquisition of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK.
EORTC Melanoma Group researchers have identified a genomic signature predicting clinical outcome in Primary Cutaneous Melanoma, after patients having undergone standard treatment.
› Verified 9 days ago
Afshin Shameli, MD, PHD Pathology Medicare: Medicare Enrolled Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5000 | |
Dr. Mark Robert, Michael Kilgore, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Box 356100, Seattle, WA 98195 Phone: 206-598-1821 Fax: 206-598-3803 | |
Corinne Lina Fligner, Pathology Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-6400 | |
Jennifer Lapointe, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195 Phone: 206-543-0065 | |
Lee-ching Zhu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Dr. Saron Ann Elizabeth Smith, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1229 Madison St Ste 820, Seattle, WA 98104 Phone: 206-576-6507 | |
Mr. Ryuji Ohashi, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Uwmc Pathology 1959 Ne Pacific, Box356100, Seattle, WA 98195 Phone: 206-598-7858 |